Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading in medicines, pharmaceuticals, vaccines-biological products, chemicals, and nutritional food products; planting of medicinal plants; and processing of medicinal herbs. In addition, the company engages in the exporting and importing of medicines, pharmaceutical materials, and medical equipment; provision of accommodation services, and commercial activities and services; buying and selling of optical, medical, dental, and hospital equipment; and repair and maintenance services for specialized medical equipment and machinery. Further, it plants and processes pharmaceutical materials, and agriculture and forestry products, as well as food supplements, cosmetics, and chemicals. The company was formerly known as Pharmaceutical and Medical Material and Equipments Joint Stock Company and changed its name to Traphaco Joint Stock Company in July 2001. Traphaco Joint Stock Company was founded in 1972 and is headquartered in Hanoi, Vietnam.
Vietnamese Market Performance
7D7 Days: 3.6%
3M3 Months: 23.8%
1Y1 Year: 27.1%
YTDYear to Date: 21.1%
The market is up 3.6% over the last week, with the Financials sector leading the way, up 5.6%. As for the past 12 months, the market is up 27%. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.